No Data
No Data
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
European Equities Traded in the US as American Depositary Receipts Sharply Down in Friday Trading
GSK Declares $0.3843 Dividend
US FDA Expands Approval of GSK's Endometrial Cancer Treatment Jemperli
Citi Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)
Kepler Capital Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
101550592 :